HRSA-22-096: Maternal and Child Health Secondary Data Analysis Research (MCH SDAR)
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants of up to $100,000 to the applicants described in the notice. It expected to make about 6 awards worth $600,000 in total. Applications closed on January 26, 2022.
From the official notice on Grants.gov, last changed October 28, 2021. Checked November 7, 2026.
- Award ceiling$100,000
- Total funding$600,000
- Expected awards6
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HRSA-23-068 | November 14, 2022 | Closed February 13, 2023 | Closed |
Key dates
| Posted | October 28, 2021 |
|---|---|
| Deadline | January 26, 2022 |
| Archived by Grants.gov | March 27, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility is limited to domestic public or non-profit institutions of higher learning and public or private non-profit agencies engaged in research or in programs relating to maternal and child health and/or services for children with special health care needs. See 42 CFR § 51a.3(b). Domestic faith-based and community-based organizations, tribes, and tribal organizations are eligible to apply.
Is this a realistic fit?
- Past Special Projects of Regional and National Significance awards averaged $1.6 million; this notice allows up to $100,000 per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Maternal and Child Health Secondary Data Analysis Research (MCH SDAR) Program. The purpose of the MCH SDAR Program is to support applied MCH research that utilizes the secondary analysis of existing national data sets and/or administrative records to improve the health and well-being of MCH populations. The MCH SDAR program provides the opportunity for researchers across the nation to build the MCH evidence base by using existing data sets, such as national data sets and/or administrative records, to identify emerging issues, study new research questions, test hypotheses, and determine pathways for intervention. Existing and emerging public health challenges affecting MCH populations including children with special health care needs require timely, evidence-based responses from MCH programs, policy, and practice. Without sufficient evidence or data, it is challenging to develop interventions addressing both existing and emerging MCH issues. This program will allow us to achieve timely, evidence-based responses to these challenges. Findings from the research supported by the MCH SDAR Program are expected to: • Strengthen and expand the evidence base on topics addressed by the Title V Maternal and Child Health Services Block Grant National Performance Measures (see Appendix A). For more background materials on the Title V Program, see: http://mchb.hrsa.gov/programs/titlevgrants/index.html. By supporting research on MCH populations, the MCH SDAR Program aims to inform HRSA Maternal and Child Health Bureau’s (MCHB’s) other investments and programs, see: https://mchb.hrsa.gov/maternal-child-health-initiatives; • Address HRSA MCHB’s Strategic Research Issues such as improving public health systems and infrastructure, reducing health inequalities, increasing quality of and access to care, addressing health disparities, improving health equity2, and/or promoting the health of MCH populations; • Address Healthy People 2030 objectives that are relevant to the application.
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-096 still open?
No. It closed on January 26, 2022. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for Maternal and Child Health Secondary Data Analysis Research (MCH SDAR)?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Maternal and Child Health Secondary Data Analysis Research (MCH SDAR)?
Closed January 26, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $100,000 each. About $600,000 in total across about 6 awards.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)